Phenazone (Antipyrine) Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Phenazone (Antipyrine) in Global, including the following market information:
Global Phenazone (Antipyrine) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Phenazone (Antipyrine) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Phenazone (Antipyrine) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phenazone (Antipyrine) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Phenazone (Antipyrine) Market Segment Percentages, By Type, 2020 (%)
China Phenazone (Antipyrine) Market Segment Percentages, By Application, 2020 (%)
Global Phenazone (Antipyrine) Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total Phenazone (Antipyrine) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Phenazone (Antipyrine) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global Phenazone (Antipyrine) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Phenazone (Antipyrine) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Phenazone (Antipyrine) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phenazone (Antipyrine) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Phenazone (Antipyrine) Market Segment Percentages, By Type, 2020 (%)
- Solution
- Liquid
China Phenazone (Antipyrine) Market Segment Percentages, By Application, 2020 (%)
- Analytical Reagent for Nitric Acid, Nitrite and Iodine
- Antipyretic And Analgesic
Global Phenazone (Antipyrine) Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total Phenazone (Antipyrine) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Phenazone (Antipyrine) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Endo
- Pfizer
- Herbages Naturbec
- Bayer
- CSPC
- Huadong Medicine
- Northeast Pharmaceutical
- NCPC
- Sinopharm
- Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
- Tianfang Pharmaceutical
- Tianjin Jinyao Pharmaceutical
- Shandong Huaxin Pharmaceutical Group
- Shandong Xinhua Pharmaceutical
- Shandong Fangming Pharmaceutical Group
- Shanxi Taiyuan Pharmaceutical
- Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
- Guangdong Sancai Shiqi District Pharmaceutical
- Guangdong Nanguo Pharmaceutical
- Kaifeng Pharmaceutical Group
- Yuekang Pharmaceutical Group Anhui Biopharmaceutical
- Xinxiang Changle Pharmaceutical
- Wuhan Fuxing Biopharmaceutical
- Henan Runhong Pharmaceutical
- Henan Furen Huaiqingtang Pharmaceutical
- Hainan Pharmaceutical Factory
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Phenazone (Antipyrine) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Phenazone (Antipyrine) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHENAZONE (ANTIPYRINE) OVERALL MARKET SIZE
2.1 Global Phenazone (Antipyrine) Market Size: 2021 VS 2027
2.2 Global Phenazone (Antipyrine) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Phenazone (Antipyrine) Players in Global Market
3.2 Top Global Phenazone (Antipyrine) Companies Ranked by Revenue
3.3 Global Phenazone (Antipyrine) Revenue by Companies
3.4 Top 3 and Top 5 Phenazone (Antipyrine) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Phenazone (Antipyrine) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phenazone (Antipyrine) Players in Global Market
3.6.1 List of Global Tier 1 Phenazone (Antipyrine) Companies
3.6.2 List of Global Tier 2 and Tier 3 Phenazone (Antipyrine) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Phenazone (Antipyrine) Market Size Markets, 2021 & 2027
4.1.2 Solution
4.1.3 Liquid
4.2 By Type - Global Phenazone (Antipyrine) Revenue & Forecasts
4.2.1 By Type - Global Phenazone (Antipyrine) Revenue, 2016-2021
4.2.2 By Type - Global Phenazone (Antipyrine) Revenue, 2022-2027
4.2.3 By Type - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Phenazone (Antipyrine) Market Size, 2021 & 2027
5.1.2 Analytical Reagent for Nitric Acid, Nitrite and Iodine
5.1.3 Antipyretic And Analgesic
5.2 By Application - Global Phenazone (Antipyrine) Revenue & Forecasts
5.2.1 By Application - Global Phenazone (Antipyrine) Revenue, 2016-2021
5.2.2 By Application - Global Phenazone (Antipyrine) Revenue, 2022-2027
5.2.3 By Application - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Phenazone (Antipyrine) Market Size, 2021 & 2027
6.2 By Region - Global Phenazone (Antipyrine) Revenue & Forecasts
6.2.1 By Region - Global Phenazone (Antipyrine) Revenue, 2016-2021
6.2.2 By Region - Global Phenazone (Antipyrine) Revenue, 2022-2027
6.2.3 By Region - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Phenazone (Antipyrine) Revenue, 2016-2027
6.3.2 US Phenazone (Antipyrine) Market Size, 2016-2027
6.3.3 Canada Phenazone (Antipyrine) Market Size, 2016-2027
6.3.4 Mexico Phenazone (Antipyrine) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Phenazone (Antipyrine) Revenue, 2016-2027
6.4.2 Germany Phenazone (Antipyrine) Market Size, 2016-2027
6.4.3 France Phenazone (Antipyrine) Market Size, 2016-2027
6.4.4 U.K. Phenazone (Antipyrine) Market Size, 2016-2027
6.4.5 Italy Phenazone (Antipyrine) Market Size, 2016-2027
6.4.6 Russia Phenazone (Antipyrine) Market Size, 2016-2027
6.4.7 Nordic Countries Phenazone (Antipyrine) Market Size, 2016-2027
6.4.8 Benelux Phenazone (Antipyrine) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Phenazone (Antipyrine) Revenue, 2016-2027
6.5.2 China Phenazone (Antipyrine) Market Size, 2016-2027
6.5.3 Japan Phenazone (Antipyrine) Market Size, 2016-2027
6.5.4 South Korea Phenazone (Antipyrine) Market Size, 2016-2027
6.5.5 Southeast Asia Phenazone (Antipyrine) Market Size, 2016-2027
6.5.6 India Phenazone (Antipyrine) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Phenazone (Antipyrine) Revenue, 2016-2027
6.6.2 Brazil Phenazone (Antipyrine) Market Size, 2016-2027
6.6.3 Argentina Phenazone (Antipyrine) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Phenazone (Antipyrine) Revenue, 2016-2027
6.7.2 Turkey Phenazone (Antipyrine) Market Size, 2016-2027
6.7.3 Israel Phenazone (Antipyrine) Market Size, 2016-2027
6.7.4 Saudi Arabia Phenazone (Antipyrine) Market Size, 2016-2027
6.7.5 UAE Phenazone (Antipyrine) Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Endo
7.1.1 Endo Corporate Summary
7.1.2 Endo Business Overview
7.1.3 Endo Phenazone (Antipyrine) Major Product Offerings
7.1.4 Endo Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.1.5 Endo Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Phenazone (Antipyrine) Major Product Offerings
7.2.4 Pfizer Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Herbages Naturbec
7.3.1 Herbages Naturbec Corporate Summary
7.3.2 Herbages Naturbec Business Overview
7.3.3 Herbages Naturbec Phenazone (Antipyrine) Major Product Offerings
7.3.4 Herbages Naturbec Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.3.5 Herbages Naturbec Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Phenazone (Antipyrine) Major Product Offerings
7.4.4 Bayer Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.4.5 Bayer Key News
7.5 CSPC
7.5.1 CSPC Corporate Summary
7.5.2 CSPC Business Overview
7.5.3 CSPC Phenazone (Antipyrine) Major Product Offerings
7.5.4 CSPC Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.5.5 CSPC Key News
7.6 Huadong Medicine
7.6.1 Huadong Medicine Corporate Summary
7.6.2 Huadong Medicine Business Overview
7.6.3 Huadong Medicine Phenazone (Antipyrine) Major Product Offerings
7.6.4 Huadong Medicine Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.6.5 Huadong Medicine Key News
7.7 Northeast Pharmaceutical
7.7.1 Northeast Pharmaceutical Corporate Summary
7.7.2 Northeast Pharmaceutical Business Overview
7.7.3 Northeast Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.4.4 Northeast Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.7.5 Northeast Pharmaceutical Key News
7.8 NCPC
7.8.1 NCPC Corporate Summary
7.8.2 NCPC Business Overview
7.8.3 NCPC Phenazone (Antipyrine) Major Product Offerings
7.8.4 NCPC Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.8.5 NCPC Key News
7.9 Sinopharm
7.9.1 Sinopharm Corporate Summary
7.9.2 Sinopharm Business Overview
7.9.3 Sinopharm Phenazone (Antipyrine) Major Product Offerings
7.9.4 Sinopharm Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.9.5 Sinopharm Key News
7.10 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
7.10.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
7.10.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
7.10.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Major Product Offerings
7.10.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.10.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Key News
7.11 Tianfang Pharmaceutical
7.11.1 Tianfang Pharmaceutical Corporate Summary
7.11.2 Tianfang Pharmaceutical Business Overview
7.11.3 Tianfang Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.11.4 Tianfang Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.11.5 Tianfang Pharmaceutical Key News
7.12 Tianjin Jinyao Pharmaceutical
7.12.1 Tianjin Jinyao Pharmaceutical Corporate Summary
7.12.2 Tianjin Jinyao Pharmaceutical Business Overview
7.12.3 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.12.4 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.12.5 Tianjin Jinyao Pharmaceutical Key News
7.13 Shandong Huaxin Pharmaceutical Group
7.13.1 Shandong Huaxin Pharmaceutical Group Corporate Summary
7.13.2 Shandong Huaxin Pharmaceutical Group Business Overview
7.13.3 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Major Product Offerings
7.13.4 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.13.5 Shandong Huaxin Pharmaceutical Group Key News
7.14 Shandong Xinhua Pharmaceutical
7.14.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.14.2 Shandong Xinhua Pharmaceutical Business Overview
7.14.3 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.14.4 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.14.5 Shandong Xinhua Pharmaceutical Key News
7.15 Shandong Fangming Pharmaceutical Group
7.15.1 Shandong Fangming Pharmaceutical Group Corporate Summary
7.15.2 Shandong Fangming Pharmaceutical Group Business Overview
7.15.3 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Major Product Offerings
7.15.4 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.15.5 Shandong Fangming Pharmaceutical Group Key News
7.16 Shanxi Taiyuan Pharmaceutical
7.16.1 Shanxi Taiyuan Pharmaceutical Corporate Summary
7.16.2 Shanxi Taiyuan Pharmaceutical Business Overview
7.16.3 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.16.4 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.16.5 Shanxi Taiyuan Pharmaceutical Key News
7.17 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
7.17.1 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Corporate Summary
7.17.2 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Business Overview
7.17.3 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Major Product Offerings
7.17.4 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.17.5 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Key News
7.18 Guangdong Sancai Shiqi District Pharmaceutical
7.18.1 Guangdong Sancai Shiqi District Pharmaceutical Corporate Summary
7.18.2 Guangdong Sancai Shiqi District Pharmaceutical Business Overview
7.18.3 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.18.4 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.18.5 Guangdong Sancai Shiqi District Pharmaceutical Key News
7.19 Guangdong Nanguo Pharmaceutical
7.19.1 Guangdong Nanguo Pharmaceutical Corporate Summary
7.19.2 Guangdong Nanguo Pharmaceutical Business Overview
7.19.3 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.19.4 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.19.5 Guangdong Nanguo Pharmaceutical Key News
7.20 Kaifeng Pharmaceutical Group
7.20.1 Kaifeng Pharmaceutical Group Corporate Summary
7.20.2 Kaifeng Pharmaceutical Group Business Overview
7.20.3 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Major Product Offerings
7.20.4 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.20.5 Kaifeng Pharmaceutical Group Key News
7.21 Yuekang Pharmaceutical Group Anhui Biopharmaceutical
7.21.1 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Corporate Summary
7.21.2 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Business Overview
7.21.3 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.21.4 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.21.5 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Key News
7.22 Xinxiang Changle Pharmaceutical
7.22.1 Xinxiang Changle Pharmaceutical Corporate Summary
7.22.2 Xinxiang Changle Pharmaceutical Business Overview
7.22.3 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.22.4 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.22.5 Xinxiang Changle Pharmaceutical Key News
7.23 Wuhan Fuxing Biopharmaceutical
7.23.1 Wuhan Fuxing Biopharmaceutical Corporate Summary
7.23.2 Wuhan Fuxing Biopharmaceutical Business Overview
7.23.3 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.23.4 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.23.5 Wuhan Fuxing Biopharmaceutical Key News
7.24 Henan Runhong Pharmaceutical
7.24.1 Henan Runhong Pharmaceutical Corporate Summary
7.24.2 Henan Runhong Pharmaceutical Business Overview
7.24.3 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.24.4 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.24.5 Henan Runhong Pharmaceutical Key News
7.25 Henan Furen Huaiqingtang Pharmaceutical
7.25.1 Henan Furen Huaiqingtang Pharmaceutical Corporate Summary
7.25.2 Henan Furen Huaiqingtang Pharmaceutical Business Overview
7.25.3 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.25.4 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.25.5 Henan Furen Huaiqingtang Pharmaceutical Key News
7.26 Hainan Pharmaceutical Factory
7.26.1 Hainan Pharmaceutical Factory Corporate Summary
7.26.2 Hainan Pharmaceutical Factory Business Overview
7.26.3 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Major Product Offerings
7.26.4 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.26.5 Hainan Pharmaceutical Factory Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Phenazone (Antipyrine) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Phenazone (Antipyrine) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHENAZONE (ANTIPYRINE) OVERALL MARKET SIZE
2.1 Global Phenazone (Antipyrine) Market Size: 2021 VS 2027
2.2 Global Phenazone (Antipyrine) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Phenazone (Antipyrine) Players in Global Market
3.2 Top Global Phenazone (Antipyrine) Companies Ranked by Revenue
3.3 Global Phenazone (Antipyrine) Revenue by Companies
3.4 Top 3 and Top 5 Phenazone (Antipyrine) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Phenazone (Antipyrine) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phenazone (Antipyrine) Players in Global Market
3.6.1 List of Global Tier 1 Phenazone (Antipyrine) Companies
3.6.2 List of Global Tier 2 and Tier 3 Phenazone (Antipyrine) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Phenazone (Antipyrine) Market Size Markets, 2021 & 2027
4.1.2 Solution
4.1.3 Liquid
4.2 By Type - Global Phenazone (Antipyrine) Revenue & Forecasts
4.2.1 By Type - Global Phenazone (Antipyrine) Revenue, 2016-2021
4.2.2 By Type - Global Phenazone (Antipyrine) Revenue, 2022-2027
4.2.3 By Type - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Phenazone (Antipyrine) Market Size, 2021 & 2027
5.1.2 Analytical Reagent for Nitric Acid, Nitrite and Iodine
5.1.3 Antipyretic And Analgesic
5.2 By Application - Global Phenazone (Antipyrine) Revenue & Forecasts
5.2.1 By Application - Global Phenazone (Antipyrine) Revenue, 2016-2021
5.2.2 By Application - Global Phenazone (Antipyrine) Revenue, 2022-2027
5.2.3 By Application - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Phenazone (Antipyrine) Market Size, 2021 & 2027
6.2 By Region - Global Phenazone (Antipyrine) Revenue & Forecasts
6.2.1 By Region - Global Phenazone (Antipyrine) Revenue, 2016-2021
6.2.2 By Region - Global Phenazone (Antipyrine) Revenue, 2022-2027
6.2.3 By Region - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Phenazone (Antipyrine) Revenue, 2016-2027
6.3.2 US Phenazone (Antipyrine) Market Size, 2016-2027
6.3.3 Canada Phenazone (Antipyrine) Market Size, 2016-2027
6.3.4 Mexico Phenazone (Antipyrine) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Phenazone (Antipyrine) Revenue, 2016-2027
6.4.2 Germany Phenazone (Antipyrine) Market Size, 2016-2027
6.4.3 France Phenazone (Antipyrine) Market Size, 2016-2027
6.4.4 U.K. Phenazone (Antipyrine) Market Size, 2016-2027
6.4.5 Italy Phenazone (Antipyrine) Market Size, 2016-2027
6.4.6 Russia Phenazone (Antipyrine) Market Size, 2016-2027
6.4.7 Nordic Countries Phenazone (Antipyrine) Market Size, 2016-2027
6.4.8 Benelux Phenazone (Antipyrine) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Phenazone (Antipyrine) Revenue, 2016-2027
6.5.2 China Phenazone (Antipyrine) Market Size, 2016-2027
6.5.3 Japan Phenazone (Antipyrine) Market Size, 2016-2027
6.5.4 South Korea Phenazone (Antipyrine) Market Size, 2016-2027
6.5.5 Southeast Asia Phenazone (Antipyrine) Market Size, 2016-2027
6.5.6 India Phenazone (Antipyrine) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Phenazone (Antipyrine) Revenue, 2016-2027
6.6.2 Brazil Phenazone (Antipyrine) Market Size, 2016-2027
6.6.3 Argentina Phenazone (Antipyrine) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Phenazone (Antipyrine) Revenue, 2016-2027
6.7.2 Turkey Phenazone (Antipyrine) Market Size, 2016-2027
6.7.3 Israel Phenazone (Antipyrine) Market Size, 2016-2027
6.7.4 Saudi Arabia Phenazone (Antipyrine) Market Size, 2016-2027
6.7.5 UAE Phenazone (Antipyrine) Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Endo
7.1.1 Endo Corporate Summary
7.1.2 Endo Business Overview
7.1.3 Endo Phenazone (Antipyrine) Major Product Offerings
7.1.4 Endo Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.1.5 Endo Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Phenazone (Antipyrine) Major Product Offerings
7.2.4 Pfizer Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Herbages Naturbec
7.3.1 Herbages Naturbec Corporate Summary
7.3.2 Herbages Naturbec Business Overview
7.3.3 Herbages Naturbec Phenazone (Antipyrine) Major Product Offerings
7.3.4 Herbages Naturbec Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.3.5 Herbages Naturbec Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Phenazone (Antipyrine) Major Product Offerings
7.4.4 Bayer Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.4.5 Bayer Key News
7.5 CSPC
7.5.1 CSPC Corporate Summary
7.5.2 CSPC Business Overview
7.5.3 CSPC Phenazone (Antipyrine) Major Product Offerings
7.5.4 CSPC Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.5.5 CSPC Key News
7.6 Huadong Medicine
7.6.1 Huadong Medicine Corporate Summary
7.6.2 Huadong Medicine Business Overview
7.6.3 Huadong Medicine Phenazone (Antipyrine) Major Product Offerings
7.6.4 Huadong Medicine Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.6.5 Huadong Medicine Key News
7.7 Northeast Pharmaceutical
7.7.1 Northeast Pharmaceutical Corporate Summary
7.7.2 Northeast Pharmaceutical Business Overview
7.7.3 Northeast Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.4.4 Northeast Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.7.5 Northeast Pharmaceutical Key News
7.8 NCPC
7.8.1 NCPC Corporate Summary
7.8.2 NCPC Business Overview
7.8.3 NCPC Phenazone (Antipyrine) Major Product Offerings
7.8.4 NCPC Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.8.5 NCPC Key News
7.9 Sinopharm
7.9.1 Sinopharm Corporate Summary
7.9.2 Sinopharm Business Overview
7.9.3 Sinopharm Phenazone (Antipyrine) Major Product Offerings
7.9.4 Sinopharm Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.9.5 Sinopharm Key News
7.10 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
7.10.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
7.10.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
7.10.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Major Product Offerings
7.10.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.10.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Key News
7.11 Tianfang Pharmaceutical
7.11.1 Tianfang Pharmaceutical Corporate Summary
7.11.2 Tianfang Pharmaceutical Business Overview
7.11.3 Tianfang Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.11.4 Tianfang Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.11.5 Tianfang Pharmaceutical Key News
7.12 Tianjin Jinyao Pharmaceutical
7.12.1 Tianjin Jinyao Pharmaceutical Corporate Summary
7.12.2 Tianjin Jinyao Pharmaceutical Business Overview
7.12.3 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.12.4 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.12.5 Tianjin Jinyao Pharmaceutical Key News
7.13 Shandong Huaxin Pharmaceutical Group
7.13.1 Shandong Huaxin Pharmaceutical Group Corporate Summary
7.13.2 Shandong Huaxin Pharmaceutical Group Business Overview
7.13.3 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Major Product Offerings
7.13.4 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.13.5 Shandong Huaxin Pharmaceutical Group Key News
7.14 Shandong Xinhua Pharmaceutical
7.14.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.14.2 Shandong Xinhua Pharmaceutical Business Overview
7.14.3 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.14.4 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.14.5 Shandong Xinhua Pharmaceutical Key News
7.15 Shandong Fangming Pharmaceutical Group
7.15.1 Shandong Fangming Pharmaceutical Group Corporate Summary
7.15.2 Shandong Fangming Pharmaceutical Group Business Overview
7.15.3 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Major Product Offerings
7.15.4 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.15.5 Shandong Fangming Pharmaceutical Group Key News
7.16 Shanxi Taiyuan Pharmaceutical
7.16.1 Shanxi Taiyuan Pharmaceutical Corporate Summary
7.16.2 Shanxi Taiyuan Pharmaceutical Business Overview
7.16.3 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.16.4 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.16.5 Shanxi Taiyuan Pharmaceutical Key News
7.17 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
7.17.1 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Corporate Summary
7.17.2 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Business Overview
7.17.3 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Major Product Offerings
7.17.4 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.17.5 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Key News
7.18 Guangdong Sancai Shiqi District Pharmaceutical
7.18.1 Guangdong Sancai Shiqi District Pharmaceutical Corporate Summary
7.18.2 Guangdong Sancai Shiqi District Pharmaceutical Business Overview
7.18.3 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.18.4 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.18.5 Guangdong Sancai Shiqi District Pharmaceutical Key News
7.19 Guangdong Nanguo Pharmaceutical
7.19.1 Guangdong Nanguo Pharmaceutical Corporate Summary
7.19.2 Guangdong Nanguo Pharmaceutical Business Overview
7.19.3 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.19.4 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.19.5 Guangdong Nanguo Pharmaceutical Key News
7.20 Kaifeng Pharmaceutical Group
7.20.1 Kaifeng Pharmaceutical Group Corporate Summary
7.20.2 Kaifeng Pharmaceutical Group Business Overview
7.20.3 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Major Product Offerings
7.20.4 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.20.5 Kaifeng Pharmaceutical Group Key News
7.21 Yuekang Pharmaceutical Group Anhui Biopharmaceutical
7.21.1 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Corporate Summary
7.21.2 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Business Overview
7.21.3 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.21.4 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.21.5 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Key News
7.22 Xinxiang Changle Pharmaceutical
7.22.1 Xinxiang Changle Pharmaceutical Corporate Summary
7.22.2 Xinxiang Changle Pharmaceutical Business Overview
7.22.3 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.22.4 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.22.5 Xinxiang Changle Pharmaceutical Key News
7.23 Wuhan Fuxing Biopharmaceutical
7.23.1 Wuhan Fuxing Biopharmaceutical Corporate Summary
7.23.2 Wuhan Fuxing Biopharmaceutical Business Overview
7.23.3 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.23.4 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.23.5 Wuhan Fuxing Biopharmaceutical Key News
7.24 Henan Runhong Pharmaceutical
7.24.1 Henan Runhong Pharmaceutical Corporate Summary
7.24.2 Henan Runhong Pharmaceutical Business Overview
7.24.3 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.24.4 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.24.5 Henan Runhong Pharmaceutical Key News
7.25 Henan Furen Huaiqingtang Pharmaceutical
7.25.1 Henan Furen Huaiqingtang Pharmaceutical Corporate Summary
7.25.2 Henan Furen Huaiqingtang Pharmaceutical Business Overview
7.25.3 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Major Product Offerings
7.25.4 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.25.5 Henan Furen Huaiqingtang Pharmaceutical Key News
7.26 Hainan Pharmaceutical Factory
7.26.1 Hainan Pharmaceutical Factory Corporate Summary
7.26.2 Hainan Pharmaceutical Factory Business Overview
7.26.3 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Major Product Offerings
7.26.4 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Revenue in Global (2016-2021)
7.26.5 Hainan Pharmaceutical Factory Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Phenazone (Antipyrine) Market Opportunities & Trends in Global Market
Table 2. Phenazone (Antipyrine) Market Drivers in Global Market
Table 3. Phenazone (Antipyrine) Market Restraints in Global Market
Table 4. Key Players of Phenazone (Antipyrine) in Global Market
Table 5. Top Phenazone (Antipyrine) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Phenazone (Antipyrine) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Phenazone (Antipyrine) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Phenazone (Antipyrine) Product Type
Table 9. List of Global Tier 1 Phenazone (Antipyrine) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phenazone (Antipyrine) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Phenazone (Antipyrine) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Phenazone (Antipyrine) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Phenazone (Antipyrine) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Phenazone (Antipyrine) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Phenazone (Antipyrine) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 30. Endo Corporate Summary
Table 31. Endo Phenazone (Antipyrine) Product Offerings
Table 32. Endo Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Phenazone (Antipyrine) Product Offerings
Table 35. Pfizer Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 36. Herbages Naturbec Corporate Summary
Table 37. Herbages Naturbec Phenazone (Antipyrine) Product Offerings
Table 38. Herbages Naturbec Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 39. Bayer Corporate Summary
Table 40. Bayer Phenazone (Antipyrine) Product Offerings
Table 41. Bayer Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 42. CSPC Corporate Summary
Table 43. CSPC Phenazone (Antipyrine) Product Offerings
Table 44. CSPC Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 45. Huadong Medicine Corporate Summary
Table 46. Huadong Medicine Phenazone (Antipyrine) Product Offerings
Table 47. Huadong Medicine Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 48. Northeast Pharmaceutical Corporate Summary
Table 49. Northeast Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 50. Northeast Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 51. NCPC Corporate Summary
Table 52. NCPC Phenazone (Antipyrine) Product Offerings
Table 53. NCPC Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 54. Sinopharm Corporate Summary
Table 55. Sinopharm Phenazone (Antipyrine) Product Offerings
Table 56. Sinopharm Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 57. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
Table 58. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Product Offerings
Table 59. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 60. Tianfang Pharmaceutical Corporate Summary
Table 61. Tianfang Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 62. Tianfang Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 63. Tianjin Jinyao Pharmaceutical Corporate Summary
Table 64. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 65. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 66. Shandong Huaxin Pharmaceutical Group Corporate Summary
Table 67. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Product Offerings
Table 68. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 69. Shandong Xinhua Pharmaceutical Corporate Summary
Table 70. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 71. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 72. Shandong Fangming Pharmaceutical Group Corporate Summary
Table 73. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Product Offerings
Table 74. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 75. Shanxi Taiyuan Pharmaceutical Corporate Summary
Table 76. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 77. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 78. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Corporate Summary
Table 79. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Product Offerings
Table 80. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 81. Guangdong Sancai Shiqi District Pharmaceutical Corporate Summary
Table 82. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 83. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 84. Guangdong Nanguo Pharmaceutical Corporate Summary
Table 85. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 86. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 87. Kaifeng Pharmaceutical Group Corporate Summary
Table 88. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Product Offerings
Table 89. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 90. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Corporate Summary
Table 91. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Product Offerings
Table 92. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 93. Xinxiang Changle Pharmaceutical Corporate Summary
Table 94. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 95. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 96. Wuhan Fuxing Biopharmaceutical Corporate Summary
Table 97. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Product Offerings
Table 98. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 99. Henan Runhong Pharmaceutical Corporate Summary
Table 100. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 101. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 102. Henan Furen Huaiqingtang Pharmaceutical Corporate Summary
Table 103. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 104. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 105. Hainan Pharmaceutical Factory Corporate Summary
Table 106. Hainan Pharmaceutical Factory Phenazone (Antipyrine) Product Offerings
Table 107. Hainan Pharmaceutical Factory Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 1. Phenazone (Antipyrine) Market Opportunities & Trends in Global Market
Table 2. Phenazone (Antipyrine) Market Drivers in Global Market
Table 3. Phenazone (Antipyrine) Market Restraints in Global Market
Table 4. Key Players of Phenazone (Antipyrine) in Global Market
Table 5. Top Phenazone (Antipyrine) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Phenazone (Antipyrine) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Phenazone (Antipyrine) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Phenazone (Antipyrine) Product Type
Table 9. List of Global Tier 1 Phenazone (Antipyrine) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phenazone (Antipyrine) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Phenazone (Antipyrine) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Phenazone (Antipyrine) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Phenazone (Antipyrine) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Phenazone (Antipyrine) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Phenazone (Antipyrine) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Phenazone (Antipyrine) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Phenazone (Antipyrine) Revenue, (US$, Mn), 2022-2027
Table 30. Endo Corporate Summary
Table 31. Endo Phenazone (Antipyrine) Product Offerings
Table 32. Endo Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Phenazone (Antipyrine) Product Offerings
Table 35. Pfizer Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 36. Herbages Naturbec Corporate Summary
Table 37. Herbages Naturbec Phenazone (Antipyrine) Product Offerings
Table 38. Herbages Naturbec Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 39. Bayer Corporate Summary
Table 40. Bayer Phenazone (Antipyrine) Product Offerings
Table 41. Bayer Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 42. CSPC Corporate Summary
Table 43. CSPC Phenazone (Antipyrine) Product Offerings
Table 44. CSPC Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 45. Huadong Medicine Corporate Summary
Table 46. Huadong Medicine Phenazone (Antipyrine) Product Offerings
Table 47. Huadong Medicine Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 48. Northeast Pharmaceutical Corporate Summary
Table 49. Northeast Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 50. Northeast Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 51. NCPC Corporate Summary
Table 52. NCPC Phenazone (Antipyrine) Product Offerings
Table 53. NCPC Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 54. Sinopharm Corporate Summary
Table 55. Sinopharm Phenazone (Antipyrine) Product Offerings
Table 56. Sinopharm Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 57. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
Table 58. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Product Offerings
Table 59. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 60. Tianfang Pharmaceutical Corporate Summary
Table 61. Tianfang Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 62. Tianfang Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 63. Tianjin Jinyao Pharmaceutical Corporate Summary
Table 64. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 65. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 66. Shandong Huaxin Pharmaceutical Group Corporate Summary
Table 67. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Product Offerings
Table 68. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 69. Shandong Xinhua Pharmaceutical Corporate Summary
Table 70. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 71. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 72. Shandong Fangming Pharmaceutical Group Corporate Summary
Table 73. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Product Offerings
Table 74. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 75. Shanxi Taiyuan Pharmaceutical Corporate Summary
Table 76. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 77. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 78. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Corporate Summary
Table 79. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Product Offerings
Table 80. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 81. Guangdong Sancai Shiqi District Pharmaceutical Corporate Summary
Table 82. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 83. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 84. Guangdong Nanguo Pharmaceutical Corporate Summary
Table 85. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 86. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 87. Kaifeng Pharmaceutical Group Corporate Summary
Table 88. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Product Offerings
Table 89. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 90. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Corporate Summary
Table 91. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Product Offerings
Table 92. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 93. Xinxiang Changle Pharmaceutical Corporate Summary
Table 94. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 95. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 96. Wuhan Fuxing Biopharmaceutical Corporate Summary
Table 97. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Product Offerings
Table 98. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 99. Henan Runhong Pharmaceutical Corporate Summary
Table 100. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 101. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 102. Henan Furen Huaiqingtang Pharmaceutical Corporate Summary
Table 103. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Product Offerings
Table 104. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
Table 105. Hainan Pharmaceutical Factory Corporate Summary
Table 106. Hainan Pharmaceutical Factory Phenazone (Antipyrine) Product Offerings
Table 107. Hainan Pharmaceutical Factory Phenazone (Antipyrine) Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. Phenazone (Antipyrine) Segment by Type
Figure 2. Phenazone (Antipyrine) Segment by Application
Figure 3. Global Phenazone (Antipyrine) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Phenazone (Antipyrine) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Phenazone (Antipyrine) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phenazone (Antipyrine) Revenue in 2020
Figure 8. By Type - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 12. US Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 16. Germany Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 17. France Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 24. China Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 28. India Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 30. Brazil Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 33. Turkey Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 37. Endo Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Herbages Naturbec Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. CSPC Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Huadong Medicine Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Northeast Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. NCPC Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sinopharm Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Tianfang Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. Phenazone (Antipyrine) Segment by Type
Figure 2. Phenazone (Antipyrine) Segment by Application
Figure 3. Global Phenazone (Antipyrine) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Phenazone (Antipyrine) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Phenazone (Antipyrine) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phenazone (Antipyrine) Revenue in 2020
Figure 8. By Type - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 12. US Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 16. Germany Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 17. France Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 24. China Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 28. India Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 30. Brazil Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Phenazone (Antipyrine) Revenue Market Share, 2016-2027
Figure 33. Turkey Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Phenazone (Antipyrine) Revenue, (US$, Mn), 2016-2027
Figure 37. Endo Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Herbages Naturbec Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. CSPC Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Huadong Medicine Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Northeast Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. NCPC Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sinopharm Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Tianfang Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
